Our team has worked with hundreds of patients navigating GLP-1 protocols who ask this exact question
The four peptides in KLOW each carry substantial preclinical research literature: BPC-157: Sikiric P et al
Biochimica et Biophysica Acta, 1822 (5), 625
Conversely, RT-qPCR and western blot assays showed that the knockdown of Pelo expression did not significantly change the transcript and protein accumulation levels of -actin and -tubulin of R
Human and human-cell studies show it increases myotube nuclei, myosin content, and anabolic signaling, supporting faster muscle recovery and growth
Note also that GSH inhibits both GCL and GS, so it is not clear by inspection of the diagram what the effect of raising the activities of GCL and GPX will be